A function-inhibiting antibody (clone 4G3) against the TG2 FN-binding domain (1–165) suppressed TG2/FN/integrin complex formation, CSCs proliferation as spheroids, tumor-initiating capacity, and stemness-associated Wnt/β-catenin signaling. This evidence concerns the gene TGM2 and neoplasm.